Navigation Links
EMD Serono, Inc. Named as a Top Employer by Science Magazine
Date:10/5/2009

ROCKLAND, Mass., Oct. 5 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's leading biotechnology and pharmaceutical employers. EMD Serono's ranking improved to No. 6 this year, up from No. 7 in 2008 and No. 17 in 2007.

"This is a great honor because the survey by Science sought opinions from people within the scientific community, people who actually know the biotech and pharmaceutical industries very well," said Dr. Bernhard Kirschbaum, Executive Vice President, Research & Development, Merck Serono, an affiliate of Merck KGaA, Darmstadt, Germany. "This is a compliment to the dedication, skills and hard work of our employees. It's also a statement to the rest of the scientific community that EMD Serono is an employer that offers a great working environment, the chance for professional development and an opportunity to help mankind."

Science's 2009 Top Employers Survey queried 2,334 people. Participants came from North America (73%), Europe (15%) and the Pacific Rim (8%). Respondents were asked to write in the names of companies they considered best, average and worst employers. They then rated these companies on 23 different attributes.

Attribute categories included Corporate Image, Financial Prowess, Leadership and Direction, Work Culture/Environment, Location, and Academic and Intellectual Challenge.

EMD Serono won special recognition for having loyal employees, being socially responsible and doing important, quality research.

EMD Serono appears on the list as Merck KGaA, Darmstadt, Germany, of which it is an affiliate.

Science and the American Association for the Advancement of Science (AAAS) commissioned Cell Associated and The Brighton Consulting Group to conduct the survey to determine which employers in the biotech and pharmaceutical industries had the
'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. American Board of Internal Medicine President Named to Alzheimers Study Group
3. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
4. Pharmaxis Establishes Named Patient Program for Bronchitol
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
8. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
9. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...MINNEAPOLIS, Nov. 20 Bio...lts for its first quarter ended September 30, 2009...ed share, on revenues of $3,263,000. This compare...d share, on revenues of $3,168,000 for the first q... quarter results, Biotel President and CEO Steve S...
(Date:11/20/2009)..., PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/...ligenix or the Company), formerly known as DOR Bio...announced today that it has formed a consortium to...TM) and other rapidly acting vaccines. Soligenix r...titute of Allergy and Infectious Diseases (NIAID),...
(Date:11/19/2009)..., TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -...pharmaceutical ingredients (APIs), announced that ...nd Safety Certification from,SafeBridge(R) Consult...,competency and proficiency in the safe handling o... and applies to specific laboratories and,producti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Karmanos Cancer Institute Receives 243 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research 59803 1Karmanos Cancer Institute Receives 243 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research 59803 2Karmanos Cancer Institute Receives 243 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research 59803 3Halifax Regional Medical Center Selects Micromedex Solutions from Thomson Reuters for Clinical Decision Support 59801 1Halifax Regional Medical Center Selects Micromedex Solutions from Thomson Reuters for Clinical Decision Support 59801 2China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 59799 1China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 59799 2China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 59799 3
...g Patterns As More MDs Question Clinical Ou...b. 7 Despite the controversy surrounding,the rele...nuary 14, 2008,physicians are less concerned now -...ults than they were initially, according to a pivo...ublishing, publishers of the FirstWord,newsletter,...
... present,data at the International Neuropsychologi... on the Posit Science(R) Brain Fitness Program(TM)..."chemobrain". "Chemobrain",is a condition associat...nition. It affects quality of life by impairing co...often limits patients, ability to deal with,daily ...
Other Medicine Technology:Physicians Reconsider Implications of Enhance Trial 2Neuroscientists Offer Hope for Breast Cancer Patients Suffering From 'Chemobrain' 2
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive...and iPod Touch. , Mountai...n,s most popular and addictive game, SplitWords, i...t Words is designed to help banish that ,tip of th...Phone brain game challenges the brain by encourag...
(Date:11/20/2009)...CETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYS...cial Meeting of Shareholders will be held on Monda...s to consider approval of two special resolutions....thorize the sale of all or substantially all of th...ovided for in the asset purchase agreement dated N...
(Date:11/20/2009)...DISON, N.J., Nov. 20 Rat...ay have peaked in late October, but the pandemic f...ness in all age groups, including the elderly, acc...orated (NYSE: DGX ), the world,s leading provide... ,, In its most recent Quest Diagnostics Healt...
(Date:11/20/2009)...GAS, Nov. 20 The follow...ector of the Nevada Health Care Association: ,,...ds and thanks Senate Majority Leader Harry Reid fo...r toward our goal of protecting every Nevada senio...nd preserving the strength and viability of our st...
(Date:11/20/2009)...ington) November 20, 2009Emergency medical service...timated 350,000 cardiac arrests each year. Only 5...rrest survive. Better quality cardiopulmonary res...ders may be associated with better patient outcome...the largest clinical research network to study pre...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...nd Wyeth merge to create a $60 billion company, wi... PhD, CEO of PharmaVentures, says, ‘This is ... Oxford, UK (PRWEB) January 23,...ays, ‘This is potentially a bad deal for bot...
...ct Market Research, a global provider of pharmaceu..., has published two new reports providing critical...ies to treat hematologic malignancies. These repo...) annual meeting. , , The first report, entitled ...
...sevier, the world,s leading publisher of scientifi...services, announced today that over 600 Medical, V...tles will be launched in Health Science eBook Coll...s W.B. Saunders, Mosby, Churchill Livingstone, and...
...n & Johnson (NYSE: JNJ ) today announced the...he cash tender offer through its wholly owned subs...g shares of common stock of Mentor Corporation (NY...depositary for the tender offer has advised Johnso...
...l.) is the first site to go clinical with Varian,s...re,s MOSAIQ(R) image-enabled oncology information ...ware, part of the Elekta Group, announces that St....treat patients using Varian,s RapidArc (TM) treatm...
...th insurance market increasingly becomes consumer-...seeking to serve customers with face-to-face assis...has its grand opening today in Mount Pleasant, S.C...officially with a ribbon cutting ceremony at 10:30...
Other Medicine News:Health News:Pfizer - Wyeth: Good Deal – Bad Deal? 2Health News:MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development 2Health News:Elsevier to launch over 600 health science e-Book titles on ScienceDirect 2Health News:Johnson & Johnson Completes Tender Offer for Mentor Corporation 2Health News:Impac Software Announces Clinical Release of RapidArc Support 2Health News:Impac Software Announces Clinical Release of RapidArc Support 3Health News:S.C. BlueCross Hosts Grand Opening of Its First Health Insurance Retail Store 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: